In one aspect, the present invention provides a method of treating breast cancer that is negative for at least one of ER, PR, or HER2, comprising administering to a subject at least one PARP inhibitor. In another aspect, the present invention provides a method of treating breast cancer comprising administering to a subject at least one PARP inhibitor in combination with at least one anti-tumor agent.

 
Web www.patentalert.com

< Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product

< Methods and compositions for RNA interference using recombinant Dicer and Argonaut

> BMP10 propeptides and related methods

> Modulation of diacylglycerol acyltransferase 2 expression
~ 00614